Download 
|
< Back |
| 01:19 PM | |
| Solara Active Pharma Sciences Limited has informed the Exchange regarding inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025 along with Limited review Report for the said period. | |
| View all announcements for Solara Active Pharma Sciences Ltd | Source: BSE India |
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback